These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19896802)

  • 1. Three methods tested to model SF-6D health utilities for health states involving comorbidity/co-occurring conditions.
    Hanmer J; Vanness D; Gangnon R; Palta M; Fryback DG
    J Clin Epidemiol; 2010 Mar; 63(3):331-41. PubMed ID: 19896802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing the Performance of 2 Health Utility Measures in the Medicare Health Outcome Survey (HOS).
    Jia H; Lubetkin EI; DeMichele K; Stark DS; Zack MM; Thompson WW
    Med Decis Making; 2018 Nov; 38(8):983-993. PubMed ID: 30403580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating health state utility values for comorbid health conditions using SF-6D data.
    Ara R; Brazier J
    Value Health; 2011; 14(5):740-5. PubMed ID: 21839413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development of a model for translation of the Neck Disability Index to utility scores for cost-utility analysis in cervical disorders.
    Richardson SS; Berven S
    Spine J; 2012 Jan; 12(1):55-62. PubMed ID: 22209244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping the cancer-specific EORTC QLQ-C30 to the preference-based EQ-5D, SF-6D, and 15D instruments.
    Kontodimopoulos N; Aletras VH; Paliouras D; Niakas D
    Value Health; 2009; 12(8):1151-7. PubMed ID: 19558372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.
    Hawton A; Green C; Telford C; Zajicek J; Wright D
    Value Health; 2012 Dec; 15(8):1084-91. PubMed ID: 23244811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting preference-based SF-6D index scores from the SF-8 health survey.
    Wang P; Fu AZ; Wee HL; Lee J; Tai ES; Thumboo J; Luo N
    Qual Life Res; 2013 Sep; 22(7):1675-83. PubMed ID: 23054496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of cancer and other chronic medical conditions with SF-6D preference-based scores in Medicare beneficiaries.
    Hays RD; Reeve BB; Smith AW; Clauser SB
    Qual Life Res; 2014 Mar; 23(2):385-91. PubMed ID: 23990395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of disease severity on EQ-5D and SF-6D utility discrepancies in chronic heart failure.
    Kontodimopoulos N; Argiriou M; Theakos N; Niakas D
    Eur J Health Econ; 2011 Aug; 12(4):383-91. PubMed ID: 20473544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catalog and comparison of societal preferences (utilities) for lung cancer health states: results from the Cancer Care Outcomes Research and Surveillance (CanCORS) study.
    Tramontano AC; Schrag DL; Malin JK; Miller MC; Weeks JC; Swan JS; McMahon PM
    Med Decis Making; 2015 Apr; 35(3):371-87. PubMed ID: 25670839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
    Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W
    Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life in cochlear implantees: comparing utility values obtained through the Medical Outcome Study Short-Form Survey-6D and the Health Utility Index Mark 3.
    Arnoldner C; Lin VY; Bresler R; Kaider A; Kuthubutheen J; Shipp D; Chen JM
    Laryngoscope; 2014 Nov; 124(11):2586-90. PubMed ID: 24536018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity and responsiveness of EQ-5D-5L and SF-6D in patients with health complaints attributed to their amalgam fillings: a prospective cohort study of patients undergoing amalgam removal.
    Lamu AN; Björkman L; Hamre HJ; Alræk T; Musial F; Robberstad B
    Health Qual Life Outcomes; 2021 Apr; 19(1):125. PubMed ID: 33865400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of diabetes mellitus and other chronic medical conditions on health-related Quality of Life: is the whole greater than the sum of its parts?
    Wee HL; Cheung YB; Li SC; Fong KY; Thumboo J
    Health Qual Life Outcomes; 2005 Jan; 3():2. PubMed ID: 15644146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting an SF-6D preference-based score using MCS and PCS scores from the SF-12 or SF-36.
    Hanmer J
    Value Health; 2009 Sep; 12(6):958-66. PubMed ID: 19490549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of EQ-5D and SF-6D utilities in Pompe disease.
    Kanters TA; Redekop WK; Kruijshaar ME; van der Ploeg AT; Rutten-van Mölken MP; Hakkaart L
    Qual Life Res; 2015 Apr; 24(4):837-44. PubMed ID: 25342117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population.
    Petrou S; Hockley C
    Health Econ; 2005 Nov; 14(11):1169-89. PubMed ID: 15942981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting SF-6D from the European Organization for Treatment and Research of Cancer Quality of Life Questionnaire scores in patients with colorectal cancer.
    Wong CK; Lam CL; Wan YF; Rowen D
    Value Health; 2013; 16(2):373-84. PubMed ID: 23538190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A National Catalog of Mapped Short-Form Six-Dimension Utility Scores for Chronic Conditions in the United States From 2010 to 2015.
    Song HJ; Heo JH; Wilson DL; Shao H; Park H
    Value Health; 2022 Aug; 25(8):1328-1335. PubMed ID: 35367137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping the Functional Assessment of Cancer Therapy-general or -Colorectal to SF-6D in Chinese patients with colorectal neoplasm.
    Wong CK; Lam CL; Rowen D; McGhee SM; Ma KP; Law WL; Poon JT; Chan P; Kwong DL; Tsang J
    Value Health; 2012 May; 15(3):495-503. PubMed ID: 22583460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.